Duopharma Biotech Berhad (KLSE: DPHARMA)
Health Care · Pharmaceuticals · MY
RM1.13
-0.88% today · -16.9% 1Y
Duopharma Biotech Berhad (KLSE: DPHARMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $266.04M.
Over the last twelve months the share price has lost 16.9%, trading between 1.12 and 1.57.
Tweenvest scores Duopharma Biotech Berhad across four factors: quality 75/100, value 80/100, growth 76/100, dividend 85/100. Its strongest factor is dividend.
DPHARMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $266.04M
- Revenue (TTM)
- $227.57M
- P/E
- 10.64
- EPS
- 0.11
- Dividend yield
- 4.03%
- Beta (5Y)
- 0.36
- 52-week high
- RM1.57
- 52-week low
- RM1.12
- Avg volume (3M)
- —
- Shares outstanding
- 961.94M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Elite Pharmaceuticals, Inc.OTCPK: ELTP | $274.78M | $0.26 | -3.74% |
| AFT Pharmaceuticals LimitedNZSE: AFT | $272.98M | NZ$4.64 | +6.18% |
| Pharmasaga Co. Ltd.TPEX: 7878 | $272.92M | NT$163.00 | -2.10% |
| Hikal LimitedBSE: 524735 | $271.94M | Rs213.45 | -2.15% |
| Fredun Pharmaceuticals LimitedBSE: 539730 | $265.41M | Rs1,553.15 | +14.79% |
| Guangdong Jiaying Pharmaceutical Co., LtdSZSE: 002198 | $263.47M | CN¥3.55 | -0.84% |
| Hunan Nucien Pharmaceutical Co., Ltd.SHSE: 688189 | $261.09M | CN¥6.41 | -0.47% |
| Celon Pharma S.A.WSE: CLN | $257.06M | zł18.96 | +1.39% |
Figures last refreshed Oct 11, 2026.